Position in BVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$2,954
-$15,333 QoQ
Shares Held
313
-84.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#138
of 155 holders
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BVS Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Parallel Advisors, LLC holds $27,350,929 across 59 Medical Devices names. BVS ranks #48 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SYK |
Stryker Corp
|
29,358 | $9,243,072 | |
| 2 | ABT |
Abbott Laboratories
|
97,529 | $8,849,781 | |
| 3 | EW |
Edwards Lifesciences Corp
|
49,120 | $4,443,395 | |
| 4 | MDT |
Medtronic plc
|
19,868 | $1,554,273 | |
| 5 | BSX |
Boston Scientific Corp
|
15,338 | $654,625 | |
| 6 | SGHT |
Sight Sciences, Inc.
|
64,395 | $349,020 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
4,246 | $271,786 | |
| 8 | DXCM |
Dexcom Inc
|
3,307 | $222,726 |
All Filings in BVS
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,954 | 313 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $18,287 | 2,003 | Shares | Sole | 2026-05-07 | |
| 2025-03-31 | $329 | 36 | Shares | Sole | 2025-04-08 | |
| 2022-06-30 | $225 | 33 | Shares | Sole | 2022-08-01 | |
| 2021-12-31 | $304 | 21 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $4,715 | 333 | Shares | Sole | 2021-11-02 | |
| No filing history on record for this holder in this stock. | ||||||